Search

Your search keyword '"Moes-Sosnowska J"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Moes-Sosnowska J" Remove constraint Author: "Moes-Sosnowska J"
23 results on '"Moes-Sosnowska J"'

Search Results

1. Analysing the molecular landscape of squamous cell carcinoma through simultaneous targeted DNA and RNA-based next-generation sequencing

2. EP16.03-014 Simultaneous Detection of FGFR Gene Aberrations in Squamous Non-small Cell Lung Cancer Using Targeted DNA- and RNA-based NGS

3. P35.08 RNA-Based Gene Alteration and Expression Analysis in Sq-NSCLC with known FGFR1 Amplification and Protein Expression Status

5. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

6. PALB2, CHEK2 and ATM rare variants and cancer risk:data from COGS

7. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

8. The Advantage of Targeted Next-Generation Sequencing over qPCR in Testing for Druggable EGFR Variants in Non-Small-Cell Lung Cancer.

9. Clinical significance of TP53 alterations in advanced NSCLC patients treated with EGFR, ALK and ROS1 tyrosine kinase inhibitors: An update.

10. FGFR1-4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer.

11. PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients.

12. Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer.

13. Detection of EGFR mutations in liquid biopsy samples using allele-specific quantitative PCR: A comparative real-world evaluation of two popular diagnostic systems.

14. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas.

15. Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer.

16. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.

17. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.

18. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer.

19. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

20. Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer.

21. Germline SMARCA4 mutations in patients with ovarian small cell carcinoma of hypercalcemic type.

22. Ovarian small cell carcinoma of hypercalcemic type - evidence of germline origin and SMARCA4 gene inactivation. a pilot study.

23. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.

Catalog

Books, media, physical & digital resources